Here, Luke discribed a new Biotech investment model. Well, I hate to said it is really not anything new. If you look into any Start Plan book, you will see that licensing is always a option for competition.
- How Many Patients Would Switch To Generics? April 10, 2011Shared by ISM Wow, 82%. That mean the patent cliff is much deeper than what I thought. However, mist generics doesn't really completely replace the patented drug. The raw material is a little different. My friend cannot use generics since she is allergic. With the brand name, she is fine. According to the Pharmalot blog, Express Scripts says the answer […](author unknown)
- President Obama's Budget February 17, 2011Via Keith Hennessey (Click on graphic to enlarge.)firstname.lastname@example.org (Greg Mankiw)
- How Many Patients Would Switch To Generics? April 10, 2011